(Q54573262)
Statements
Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. (English)
1 reference
1 reference
Donna McBain
1 reference
Lisa Petrlich
1 reference
Sharon Watson
1 reference
Louise Vanderhoek
1 reference
Faye de Leon
1 reference
Shannon Seney
1 reference
Kelly Summers
1 reference
1 November 2011
1 reference
63
1 reference
11
1 reference
3547-3551
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference